GSK in China: A Game Changer in Compliance, by Thomas Fox

GSK in China: A Game Changer in FCPA Compliance

GSK in China: A Game Changer in Compliance, by Thomas FoxHOUSTON, AUG. 22, 2013 — /PRNewswire/ — A new e-book published by attorney, author and Foreign Corrupt Practices Act (FCPA) expert Tom Fox is pulling back the curtain on this summer’s bribery accusations leveled by the Chinese government against pharmaceutical giant GlaxoSmithKline.

In “GSK in China: A Game Changer in Compliance,” Mr. Fox explores the many unusual elements of the case, in which company employees are accused of bribing Chinese doctors and other officials to encourage the use of Glaxo drugs.

“As bad as it seems, there are many lessons that compliance officers can draw from and use as teachable moments within their own companies,” Mr. Fox says.

Available through Amazon’s Kindle for $4.99, this is the first e-book for Mr. Fox, a Houston lawyer and author of two previous books on corporate compliance in foreign lands.

His “FCPA Compliance and Ethics Blog” was named one of the Top 25 Business Law Blogs in 2010 and 2011 by LexisNexis.

Read more …